• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [17111 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     NIHR Health Services and Delivery Research programme The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60-89 years with dementia and qualitative exploration of individual, carer and professional perspectives
2016     Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment
2016     National Institute for Health and Care Excellence (NICE) Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia. NICE technology appraisal guidance 425
2016     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for diffuse large B-cell lymphoma – maintenance therapy
2016     NIHR Health Services and Delivery Research programme Determining the optimal model for role substitution in NHS dental services in the UK: a mixed-methods study
2016     Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation
2016     National Institute for Health and Care Excellence (NICE) Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia. NICE technology appraisal guidance 426
2016     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial
2016     NIHR Horizon Scanning Centre (NIHR HSC) Dabrafenib (Tafinlar) and trametinib (Mekinist) combination therapy for advanced BRAF mutated non-small cell lung cancer
2016     Adelaide Health Technology Assessment (AHTA) Microwave tissue ablation for primary and secondary liver cancer
2016     Health Quality Ontario (HQO) Levonorgestrel-releasing intrauterine system (52 mg) for idiopathic heavy menstrual bleeding: OHTAC Recommendation
2016     NIHR Horizon Scanning Centre (NIHR HSC) ADI-PEG 20 for hepatocellular carcinoma – second line
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2016     NIHR Health Technology Assessment programme An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK
2016     NIHR Horizon Scanning Centre (NIHR HSC) Heartcel for heart failure in patients at risk of incomplete revascularisation following coronary artery bypass graft
2016     NIHR Public Health Research (PHR) programme IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Furosemide sc2Wear micro-pump patch for oedema in heart failure
2016     NIHR Health Services and Delivery Research programme Getting the most out of knowledge and innovation transfer agents in health care: a qualitative study
2016     NIHR Health Technology Assessment programme A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) with chemotherapy and trastuzumab for HER2-positive early breast cancer – adjuvant therapy
2016     NIHR Health Services and Delivery Research programme Location of care for people with serious mental illness (LOCAPE): implications for service use and costs using a mixed-methods approach
2016     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L for graft vs host disease in paediatric patients – second line
2015     Institute for Clinical Evaluative Sciences (ICES) The mental health of children and youth in Ontario: a baseline scorecard
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for PD-L1 strong-positive metastatic non-small cell lung cancer – first line
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Hysteroscopy for abnormal uterine bleeding: review of clinical evidence and guidelines
2015     Institute for Clinical Evaluative Sciences (ICES) Atlas of childhood cancer in Ontario 1985-2004
2015     NIHR Horizon Scanning Centre (NIHR HSC) Glycerol phenylbutyrate (Ravicti) for urea cycle disorders (hyperammonaemia)
2015     NIHR Horizon Scanning Centre (NIHR HSC) GSK2696273 for severe combined immunodeficiency due to adenosine deaminase deficiency
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Holkira (ombitasvir/paritaprevir/ ritonavir with dasabuvir) and Harvoni (ledipasvir/sofosbuvir) for chronic hepatitis C: a review of the clinical evidence
2015     NIHR Horizon Scanning Centre (NIHR HSC) Lopixibat for progressive familial intrahepatic cholestasis in paediatric patients
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for Crohn's disease, in patients intolerant or with an unsatisfactory response to immunosuppressive drugs and/or TNF-inhibitors
2015     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for primary and relapse-free secondary progressive multiple sclerosis – first line
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Telehealth services for the treatment of psychiatric issues: clinical effectiveness, safety, and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for rheumatoid arthritis – second and subsequent line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sirukumab for rheumatoid arthritis
2015     NIHR Health Technology Assessment programme A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Electroconvulsive therapy performed outside of surgical suites: a review of the clinical effectiveness, safety, and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tadalafil (Cialis) for Duchenne muscular dystrophy
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ataluren (Translarna) for CFTR class I nonsense mutation mediated cystic fibrosis
2015     NIHR Health Services and Delivery Research programme Secondary analysis and literature review of community rehabilitation and intermediate care: an information resource
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A meta-analysis of diagnostic test accuracy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Benralizumab for uncontrolled asthma – second line
2015     Agency for Healthcare Research and Quality (AHRQ) Emerging approaches to diagnosis and treatment of non–muscle-invasive bladder cancer
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate osseointegrated implants for cancer patients: a review of clinical and cost-effectiveness
2015     NIHR Horizon Scanning Centre (NIHR HSC) Abiraterone (Zytiga) for hormone-naïve metastatic prostate cancer – first line
2015     Health Council of the Netherlands Gezondheidsraad (GR) Next generation sequencing in diagnosis
2015     HAYES, Inc. Continuous glucose monitoring systems
2015     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) with lomustine for glioblastoma – second line
2015     Health Council of the Netherlands Gezondheidsraad (GR) Checking checked: appropriate use of health checks
2015     HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2015     NIHR Horizon Scanning Centre (NIHR HSC) Dacomitinib for locally advanced or metastatic EGFR positive non-small cell lung cancer – first line
2015     Health Council of the Netherlands Gezondheidsraad (GR) Adriamycine. Health-based calculated occupational cancer risk values
2015     HAYES, Inc. Endoscopic therapy for gastroesophageal reflux disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Fulvestrant (Faslodex) for advanced or metastatic, hormone-receptor positive breast cancer – first line
2015     Health Council of the Netherlands Gezondheidsraad (GR) Neonatal screening: new recommendations
2015     HAYES, Inc. Intensity modulated radiation therapy (IMRT) for anal or rectal cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib (Zydelig) with bendamustine and rituximab for chronic lymphocytic leukaemia – first line
2015     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015     Health Quality Ontario (HQO) Positional Magnetic Resonance Imaging for people with Ehlers-Danlos Syndrome or suspected craniovertebral or cervical spine abnormalities: an evidence-based analysis
2015     HAYES, Inc. Lumbar total disc replacement for degenerative disc disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for diffuse large B cell lymphoma –second line
2015     NIHR Public Health Research (PHR) programme How effective are interventions at reducing socioeconomic inequalities in obesity among children and adults? Two systematic reviews
2015     Health Council of the Netherlands Gezondheidsraad (GR) Antibiotics in hospitals: prophylaxis and antibiotic stewardship
2015     Health Quality Ontario (HQO) Positional magnetic resonance imaging for people with Ehlers-Danlos syndrome or suspected craniovertebral or cervical spine abnormalities: OHTAC recommendation
2015     HAYES, Inc. PCSK9 inhibitors for cholesterol reduction: evolocumab
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Transoral robotic surgery: a review of clinical and cost-effectiveness
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for recurrent glioblastoma – second line
2015     Agency for Healthcare Research and Quality (AHRQ) Cognitive outcomes after cardiovascular procedures in older adults: a systematic review
2015     Health Council of the Netherlands Gezondheidsraad (GR) Chlorpromazine - Evaluation of the effects on reproduction, recommendation for classification
2015     Institute of Health Economics (IHE) Rheumatoid arthritis in a policy perspective: a registry for research and better treatment of Albertans
2015     HAYES, Inc. Percutaneous left appendage closure to reduce stroke risk in patients with atrial fibrillation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab treated patients – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Crizotinib (Xalkori) for ALK-positive, locally advanced or metastatic, non-small cell lung cancer — first line
2015     Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: ledipasvir-sofosbuvir
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for Hodgkin lymphoma in brentuximab naïve patients – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Erythrocyte encapsulated asparaginase (GRASPA) for acute lymphoblastic leukaemia — second line
2015     Agency for Healthcare Research and Quality (AHRQ) Management strategies to reduce psychiatric readmissions
2015     Institute of Health Economics (IHE) Optimizing adoption and diffusion of medical devices at the system level
2015     HAYES, Inc. Second-wave direct-acting antivirals for hepatitis C: sofosbuvir
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab (Opdivo) for recurrent or metastatic squamous cell carcinoma of the head and neck – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) with paclitaxel and carboplatin for stage IV or recurrent non-small cell lung cancer
2015     Agency for Healthcare Research and Quality (AHRQ) Core functionality for pediatric electronic health records
2015     HAYES, Inc. Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Olaratumab with doxorubicin for advanced soft tissue sarcoma
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for chemotherapy-naïve hormone-relapsed metastatic prostate cancer
2015     NIHR Health Technology Assessment programme Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis
2015     HAYES, Inc. Ultrasound bone growth stimulation
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pembrolizumab (Keytruda) for advanced or metastatic urothelial cancer – second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Padeliporfin (Tookad soluble) for localised prostate cancer – first line
2015     NIHR Health Technology Assessment programme An external pilot study to test the feasibility of a randomised controlled trial comparing eye muscle surgery against active monitoring for childhood intermittent exotropia [X(T)]
2015     HAYES, Inc. Decipher prostate cancer classifier
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pegaspargase (Oncaspar) for acute lymphoblastic leukaemia
2015     HAYES, Inc. Autologous fat grafting for breast reconstruction after breast cancer surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib (Stivarga) for hepatocellular carcinoma – second line